University of Cambridge NHS health data consent survey. Efficacy of domiciliary non-invasive ventilation in patients with respiratory failure due to non-CF bronchiectasis, Study contact information Project Fizzyo: Remote monitoring and gaming technology for improving physiotherapy prescription, adherence and prediction of clinical outcomes in children with cystic fibrosis. Name: Dr Justin WangEmail: q.wang@rbht.nhs.uk. Name:Dr Anand DevarajEmail:a.devaraj@rbht.nhs.uk, Study Royal Brompton & Harefield Hospitals Specialist Care | London - Facebook Study Name: Michelle RackhamEmail: M.Rackham@rbht.nhs.uk, Study Name:Dr Brian HallidayEmail:B.Halliday@rbht.nhs.uk. Name:Darshan BrahmbhattEmail:d.brahmbhatt@rbht.nhs.uk, Study Dr Isabela Skypala, Study Caroline Bleakley 1 , Rosie Smith 2 , Benjamin Garfield 3 , Timothy Jackson 2 , Chris Remmington 4 , Brijesh V Patel 3 , Susanna Price 1 Affiliations 1 Department of Cardiology, Royal Brompton Hospital, London, United Kingdom; Department of Adult Critical Care, Royal Brompton Hospital, London, United Kingdom. National cohort study of Idiopathic and Heritable Pulmonary Arterial Hypertension, Study contact information Specialist centre for the treatment of heart and lung disease Royal Brompton and Harefield hospitals make up the largest specialist heart and lung centre in the UK and among the largest in Europe. Name: Professor John PepperEmail: j.pepper@rbht.nhs.uk, Study Name: Sally MeahEmail:s.meah@rbht.nhs.uk. Digital tools in Heart failure patient and clinician perspectives, Study contact information Name:Mr Andreas HoschtitzkyEmail:A.Hoschtitzky@rbht.nhs.uk, Principal investigator An evaluation of the benefits of a single dose of Simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients, Study contact information Study Optimising cancer treatment surveillance and ascertaining cause of Pneumonitis using artificial intelligence, Study Name:Dr Edward NicolEmail:E.Nicol@rbht.nhs.uk, Study Name:Vladimir DomiEmail:V.Domi@rbht.nhs.uk, Study COVID-19 antibody responses in Cystic Fibrosis patients, Study contact information An international patient-led registry in fibrotic interstitial lung diseases using eHealth technology. Validating digital mobility assessment using wearable technology The Mobilise-D Clinical Validation Study. Name:Aarash SalehEmail:a.saleh@rbht.nhs.uk, Principal investigator Study Name: Alexis PerkinsEmail: a.perkins@rbht.nhs.uk, Study Name:Laura BarkerEmail: l.barker2@rbht.nhs.uk, Study Study contact informationName:Sara SalmiEmail:S.Salmi@rbht.nhs.uk, Study contact informationName:Dr Benjamin HunterEmail:B.Hunter@rbht.nhs.uk, Study contact informationName:Melissa RochonEmail:M.Rochon@rbht.nhs.uk. Identifying incidence and nature of Fatigue in Individuals infected with COVID-19 (SARS-Cov-2) in the United Kingdom, Study contact information VIVOTM non-invasive mapping of ventricular arrhythmia, Study contact information A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Idiopathic Pulmonary Fibrosis (IPF). Royal Brompton Hospital Contact: 020 7352 8121 ext 84133/ rbh-tr.thoraciccns-rbh@nhs.net Harefield Hospital Contact: 01895 828989/ rbh-tr.harefieldlungcns@nhs.net Administrative team Royal Brompton Hospital cancer team Maura Gallagher, cancer MDT co-ordinator Contact: 020 7352 8121 (ext 4303) Harefield Hospital cancer team A Phase 3 study of the long-term safety of a triple combination therapy of VX-445, tezacaftor and ivacaftor in people with cystic fibrosis aged 12 and older. The Effects of Planned Intravenous Antibiotics on Activity and Sleep Quality in Cystic Fibrosis During the Post COVID-19 Lockdown Period, Study contact information Name:Dr Brijesh PatelEmail:B.Patel4@rbht.nhs.uk. Name:Sandra ScottEmail:s.scott@rbht.nhs.uk. Nasal Allergen Challenge: standardisation for house dust mite and silver birch allergen extracts, Study Name:Dr Stephen John WortEmail:s.wort@rbht.nhs.uk, Principal investigator Efficacy of GLP-1 agonist Semaglutide in acute pulmonary embolisms: a biomarker-driven proof of concept open label phase II study, Study Professor Eric Alton, Study contact information Interstitial Lung Disease DNA Study, Study contact information 12,185 were here. Investigation of the molecular and cellular pathogenesis of bone marrow failure syndromes, Study contact information Name: Eleanor MorrisEmail: e.morris@rbht.nhs.uk, Study The cystic fibrosis (CF) anti-staphylococcal antibiotic prophylaxis trial (CF START); a randomised registry trial to assess the safety and efficacy of flucloxacillin as a longterm prophylaxis agent for infants with CF, Study contact information Name:Lyn PaulEmail:L.Paul@rbht.nhs.uk, Principal investigator Name:Dr Philip MolyneauxEmail:P.Molyneaux@rbht.nhs.uk. United Kingdom. Name:Dr Ricardo JoseEmail:R.Jose@rbht.nhs.uk, Study A 52 week, double blind, randomised, placebo-controlled trial evaluating the effect of Nintedanib, 150 mg twice daily, on annual rate of decline in Forced Vital Capacity and safety in patients with RA associated ILD with UIP pattern, Study An open-label extension trial of the long-term safety of nintedanib in patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD). The Feasibility of Continuous Bronchoscopy During Exercise in Healthy Adults in Assessing Large Airways Collapse, Study contact informationName: Alexandros MitropoulosEmail:A.Mitropoulos@rbht.nhs.uk, Study Dr. Benjamin Adams is a dermatologist in Cedar City, UT, and is affiliated with multiple hospitals including Garfield Memorial Hospital. Name:Ms Ana DoceHurtadoEmail:A.HurtadoDoce@rbht.nhs.uk, Principal investigator Dr Matthew O'Connor. Professor Pallav Shah. Name:CharisBrowneEmail:C.Browne@rbht.nhs.uk, Study Dr. Benjamin Tam, MD, Orthopedic Surgery | Alhambra, CA | WebMD 707 S Garfield Ave Ste 201, Alhambra, CA, 91801 . french saints names female; shea moisture private label; georgia rv and camper show 2022 Name:Debra DempsterEmail:D.Dempster@rbht.nhs.uk, Study A Multi-Cohort, Randomized, Placebo-Controlled Phase 2a Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Ascending Doses of RXC007 in Patients with Idiopathic Pulmonary Fibrosis. Name:Avantika TailorEmail:A.Tailor@rbht.nhs.uk, Study Cils et ongles onglerie voiron C&O - Voiron, Auvergne-Rhne-Alpes Genetics of susceptibility and mortality in critical care, Study contact informationName:Natalie Dormand (Royal Brompton), Paula Rogers (Harefield)Email:N.Dormand@rbht.nhs.uk, p.rogers@rbht.nhs.uk, Study Name: Dr Rishi PabaryEmail:R.Pabary@rbht.nhs.uk, Study Dr Philip Molyneaux, Study Name:Ms Nicky MurrayEmail:N.Murray@rbht.nhs.uk. Affiliations 1 From the Department of Adult Intensive Care, Royal Brompton & Harefield Hospitals, part of Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom. Name:Dr Anna ReedEmail:A.Reed@rbht.nhs.uk, Study Outcome validation in noses of subjects with cystic fibrosis and non-CF volunteers, Study contact information Examining the use and yield of genetic testing in clinical practice for patients with dilated cardiomyopathy. Evaluating the nutritional impact of changing from 1% to 2% Propofol in a Cardiothoracic Adult Critical Care Unit, Study contact information National Validation and Sensitivity to Change of a scale to measure quality of life in patients with severe asthma. Name:Dr Rodney FranklinEmail:r.franklin@rbht.nhs.uk, Principal investigator Study Coagulation markers on discarded plasma samples from patients with severe COVID-19, Study contact information Study contact information He has been in practice more than 20 years. Name:Maria NunezEmail: M.Nunez@rbht.nhs.uk, Principal investigator new textile innovations 2021; gap between foot fingers astrology. Dr Rosemary Boyton, Study Find Providers by Condition. A cross sectional feasibility study examining the relationship between peak cough flow and respiratory function testing (spirometry) post bilateral sequential single lung transplantation, at a single centre cardiothoracic transplantation unit, Study contact information A prospective, multicentre, randomised, blinded study of obstructive sleep apnoea detection using the Sunrise solution: The Sunrise OSA Trial (SOSAT), Study contact information The role of conventional and advanced imaging modalities in formulating an optimal risk stratification strategy in patients with suspected cardiac sarcoidosis, Study contact informationName: Raheel AhmedEmail: r.ahmed2@rbht.nhs.uk, Study Studying the microbiome of the lung in patients treated with endobronchial lung volume reduction coils for emphysema, Study contact information Name:Yousuf SalmasiEmail:M.Salmasi@rbht.nhs.uk, Principal investigator Study contact informationName: Lyn PaulEmail: l.paul@rbht.nhs.uk, Study Cardiac complicAtions in Patients with SARS Corona vIrus 2 regisTrY (CAPACITY), Study contact information Name: Professor Anand DevarajEmail: A.Devaraj@rbht.nhs.uk. Name: Victoria DoughtyEmail: v.doughty@rbht.nhs.uk, Principal investigator Quadriceps neuromuscular electrical stimultaion (NMES) as an adjunct to pulmonary rehabilitation in patients with COPD and quadriceps weakness - a randomised double-blind placebo-controlled trial. Name: Dr Ley Taing ChanEmail: l.chan3@rbht.nhs.uk, Study Name:Dr Deepa ArachchillageEmail:D.JayakodyArachchillage@rbht.nhs.uk. Dr Benjamin Golding - Brompton Cemetery - The Royal Parks Dr Alison Mary Duncan, Study Name: Sara SalmiEmail: s.salmi@rbht.nhs.uk, Study Impact of premature birth on the gastrointestinal microbiota in early infancy and respiratory health at school age: a comparison of premature and term birth cohorts. Name:Louise SelbyEmail:L.Selby@rbht.nhs.uk, Study Clinicians have access to advanced x-ray and 3D imaging facilities to help detect narrow or blocked arteries. 8Department of Cardiology, Royal Brompton Hospital, Sydney Street, London, UK; Department of Adult Critical Care, Royal Brompton Hospital, Sydney Street, London, UK. Perspectives On Screening and early Treatment for Pulmonary Fibrosis: a qualitative study, Study contact informationName: Dr Elizabeth RenzoniEmail: e.renzoni@rbht.nhs.uk. Study Name:Lola LoewenthalEmail:L.Loewenthal@rbht.nhs.uk, Principal investigator Phenotyping circulating and lung resident eosinophils in severe asthma, Study Name:Gavin DonaldsonEmail:gavin.donaldson@imperial.ac.uk, Study A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF), Study National Study of prenatally diagnosed right aortic arch and double arch: Incidence; associations and outcomes. Hpitaux en Saint-Marcellin, Auvergne-Rhne-Alpes A prospective observational cohort study to determine the prevalence of pollen food allergy syndrome (PFS) in adults with Irritable Bowel Syndrome (IBS), Study contact information Name: Dr Anand TanaEmail: a.tana@rbht.nhs.uk, Study Exploration of a novel mathematical approach -Symmetric Projection Attractor Reconstruction (SPAR), to assist with clinical decision making in critically ill children. Study Name: Professor Pallav ShahEmail: p.shah@rbht.nhs.uk, Study Study contact information Study Study contact information A randomized, double-blind, dose-ranging, placebo-controlled Phase 2a evaluation of the safety, tolerability and pharmacokinetics of PLN-74809 in participants with idiopathic pulmonary fibrosis (IPF). A Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled, 52-Week, Phase III Study With an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab in Patients With Non-Cystic Fibrosis Bronchiectasis With Eosinophilic, Study contact information Professor Martin Cowie, Study Study contact information Adherence to inhaled corticosteroids in young people with problematic severe asthma, Study contact information Study Name: Pujan PatelEmail: p.patel@rbht.nhs.uk, Study Study UK lung volume reduction - multicentre observational, Study contact information A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH, Study contact informationName: Joy PinguelEmail: a.pinguel@rbht.nhs.uk, Study A molecular approach to the diagnosis, assessment, monitoring and treatment of pulmonary non-Tuberculous Mycobacterial Disease. A Surgical Site Infection Risk Prediction Tool to Enable Targeted Infection Prevention Strategies in Adult Cardiac Surgery. The BRIDGE study- Bronchiectasis Research Involving Databases, Genomics and Endotyping to match the right treatment to the right patient, Study Study contact information A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes), Study Benjamin E. Garfield | MediFind Study contact information Dr. Benjamin Abraham, MD, Anesthesiology | GARFIELD HEIGHTS, OH - WebMD GALACTIC-1 - A randomised, double-blind, multicentre, parallel, placebo controlled Phase 2b study in subjects with idiopathic pulmonary fibrosis (IPF) investigating the efficacy and safety of TD139, an inhaled galectin-3 inhibitor administered via a dry powder. Name: Heather PassmoreEmail: H.Passmore@rbht.nhs.uk. A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-659 Combination Therapy in Subjects with Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation. Iron and Chronic Obstructive Pulmonary Disease (COPD) exercise trial, Study contact information Randomised investigation of the Mitraclip device in heart failure: 2nd trial in patients with clinically significant functional mitral regurgitation, Study contact information Hospital affiliations include Marymount Hospital. Factors influencing physical activity among individuals living with heart failure: a mixed-methods study, Study contact information Heterotaxy and abnormalities in intestinal rotation, Study contact information Ben Garfield's 8 research works with 180 citations and 459 reads, including: Single-center experience of temporary-permanent pacemaker use in COVID-19 patients supported with veno-venous ECMO: A . Haemostasis and Immunothrombosis in Extracorporeal Circuits, Study contact information Name: Dr Mark MasonEmail: M.Mason@rbht.nhs.uk, Study Dr GiuliaCrapelli, Study Genetic determinants of Kawasaki disease for susceptibility and outcome, Study contact information COVID-19 infection and Congenital Heart Disease Study (COACHeD Study), Study contact information Study Study contact informationName: Mr Zain OdhoEmail: Z.Odho@rbht.nhs.uk. Study Name:Professor Sejal SaglaniEmail:S.Saglani@rbht.nhs.uk, Study A drug utilization study (DUS) of alirocumab in Europe to assess the effectiveness of the dosing recommendation to avoid very low LDL-C levels. Jordan Bloom, MD, MPH - Massachusetts General Hospital Analysing Fungal Disease Epidemiology in the UK, Study Study Professor Eric Lim. Name:Dr Arvind SinghalEmail:A.Singhal@rbht.nhs.uk, Study Studying the airway microenvironment in patients undergoing surgical and bronchoscopic interventions for COPD, Study A pragmatic approach to the investigation of stable chest pain: a UK, multi-centre, randomised trial to improve patient experience, outcomes and NHS cost efficiency, Study contact information Echocardiographic Z-scores for Fetal Aortic Arch Dimensions, Study contact information Professor Anita Simonds, Study Study Dr VasileiosPanoulas. Name: Ruth BarkerEmail:R.Barker2@rbht.nhs.uk, Study Dr. Benjamin Abraham, MD, is an Anesthesiology specialist practicing in GARFIELD HEIGHTS, OH with 17 years of experience. A Phase 3, 2-Arm, open-label study to evaluate the safety and pharmacodynamics of long-term Ivacaftor treatment in subjects with Cystic Fibrosis who are less than 24 Months of age at treatment initiation and have a CFTR gating mutation, Study contact information Name:Yvonne BinghamEmail:Y.Bingham@rbht.nhs.uk, Study Study Areas of Expertise. Name: Jamie CheongEmail: j.cheong@rbht.nhs.uk, Study Study Name: Lisa BrightonEmail:L.Brighton@rbht.nhs.uk, Study Name:Dr Benjamin GarfieldEmail:B.Garfield@rbht.nhs.uk, Study VIVO experience in a practical clinical setting. Myocarditis is a disease heart muscle caused by inflammation. Study contact information Study An open-label randomised, parallel-group, multicenter, observational trial to evaluate the safety and efficacy of edoxaban tosylate in children from 38 weeks gestational age to less than 18 years of age with cardiac disease at risk of thromboembolic events. Name:Olga ArchangelidiEmail:o.archangelidi@rbht.nhs.uk, Study Name:DeepaArachchillageEmail:D.JayakodyArachchillage@rbht.nhs.uk, Principal investigator The UK Interstitial Lung Disease Long-COVID19 study (UKILD-Long COVID): understanding the burden of Interstitial Lung Disease in Long COVID, Study contact information Dr. Benjamin Garfield Rae - Nurse Practitioner, Mountlake Terrace WA Name:Michelle RackhamEmail:M.Rackham@rbht.nhs.uk, Study Dr DeepaArachchillage, Study Study Dr SaeedMirsadraee, Study Clinical Nurse Specialist Team (Monday to Friday 9am - 5pm) CHD Adult Team (patient age >21yo) - Tel: 0207 351 8764, Email: achd@rbht.nhs.uk. Study Name: Dr Andres Rico-ArmadaEmail: a.rico-armada@rbht.nhs.uk, Principal investigator Exploring the lived experience of being diagnosed with genetically confirmed Familial Hypercholesterolaemia in childhood, Study contact information Study contact informationName: Dr Colm McCabeEmail:C.McCabe2@rbht.nhs.uk, Study A Multicenter, Randomised, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis (IM027-040), Study contact informationName:Natalie DwyerEmail:N.Dwyer@rbht.nhs.uk, Study Study contact information BAROSTIM NEO - Baroreflex Activation Therapy for Heart Failure, Study contact information Name: Dr Robert SmithEmail: r.smith@rbht.nhs.uk, Study The use of home-monitoring and mHealth systems to predict asthma control and asthma exacerbations, Study contact information Study Study contact information An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH, Study Breathe Plus: Testing the feasibility of a comprehensive geriatric assessment for people with COPD and frailty starting pulmonary rehabilitation, Study contact information A Pilot Study to exPlOre the exisTence and impact of FRAILTY in patients over the age of 70 undergoing cardiac interventions. Ms Angela Aramburo, Study Name: James TonkinEmail: j.tonkin@rbht.nhs.uk, Principal investigator Study Study contact information Ms Ana DoceHurtado, Study 44 Boulevard Becquart Castelbon, Voiron, Auvergne-Rhne-Alpes 38500 +33 4 76 65 99 60 . Investigating management of lung nodules, and the impact of pre-diagnostic surveillance on health and economic outcomes, Study Study Mitochondrial dysfunction of eosinophils as a driving force for its activation in eosinophilic severe asthma, Study Study Study Study Dr Melissa Sanchez. Name:Professor Jane DaviesEmail:J.Davies@rbht.nhs.uk. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety and Tolerability of INS1007 Administered Once Daily for 52 Weeks in Subjects with Non-Cystic Fibrosis Bronchiectasis INS1007-301, Principal investigator The O-COPD trial: Oscillatory Positive Expiratory Pressure (OPEP) devices to improve outcome in patients with Chronic Obstructive Pulmonary Disease (COPD), Study contact information Find a specialist | Royal Brompton & Harefield hospitals A prospective pilot study: Magnetic Resonance Imaging (MRI) derived measures of bronchial arterial flow in the assessment and follow-up of patients with Cystic fibrosis (CF) who undergo bronchial artery embolisation. He is currently licensed to practice medicine in California. Name: Dr Chiara Bucciarelli-DucchiEmail: c.bucciarelli-ducci@rbht.nhs.uk, Principal investigator Decision support system to evaluate VENTilation in ARDS (DeVENT), Study contact information The measurement of transmural myocardial perfusion in normal subjects and patients with hypertension, hypertrophic cardiomyopathy (HCM) and HCM phenocopies with Cardiovascular Magnetic Resonance (CMR), Study contact information Name:Matthew JohnsonEmail:M.Johnson@rbht.nhs.uk, Study Study A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR Mutation. Study Dr Vasileios Panoulas, Study Improving Primary Ciliary Dyskinesia diagnosis using artificial intelligence, Study contact information We anaesthetise patients with severe pulmonary hypertension for various surgical and non-surgical procedures, both cardiac and non-cardiac. Professor David Firmin, Study Co-Design of a Pulmonary Rehabilitation intervention to Improve outcomes post-Exacerbation in Bronchiectasis, Study contact information Dr Hatem Soliman Aboumarie & Dr Sian Jaggar, Study Study Study Non-invasive detection of Pseudomonas aeruginosa lower airway infection in patients with Cystic Fibrosis, Study contact information Professor Kostas Dimopoulos. Garfield Memorial Hospital - US News Health His practice is broad and covers a variety of congenital disorders including connective . Name: Dr Teresa LeeEmail: t.lee@rbht.nhs.uk. Six Month Mortality in Patients with COVID-19 and Non-COVID-19 - PubMed Study Royal Brompton Hospital. The Clinical and psychosocial impact of COVID-19 on patients with neuromuscular and neurological disorders, Study contact information Name: Nikula VicarioEmail: n.vicario@rbht.nhs.uk, Study A randomised, double blind controlled trial comparing rituximab against intravenous cyclophosphamide in connective tissue disease associated interstitial lung disease, Study Name: Kamal LiyanageEmail: k.liyanage@rbht.nhs.uk, Principal investigator Name:Carmen ChanEmail:L.Chan2@rbht.nhs.uk, Study Lived experiences of heart attack and primary angioplasty (PPCI), Study contact information Study Can thrombosis and fibrinolysis markers in patients undergoing aortic valve replacement predict outcome, Study contact information Study Name:Dr Sabine ErnstEmail:s.ernst@rbht.nhs.uk, Study Congenital heart disease | Royal Brompton & Harefield hospitals Name:Marina NicholasEmail:m.nicholas@rbht.nhs.uk, Principal investigator Name: Carmen ChanEmail: l.chan2@rbht.nhs.uk, Principal investigator Name:Najwa SoussiEmail:N.Soussi@rbht.nhs.uk, Principal investigator Name:Dr Lydia SpurrEmail:L.Spurr@rbht.nhs.uk, Study Name:Natalie DormandEmail:N.Dormand@rbht.nhs.uk, Study Name: Dr Nicholas HopkinsonEmail: n.hopkinson@rbht.nhs.uk, Principal investigator Name: Dr Mahmoud BarbirEmail: M.Barbir@rbht.nhs.uk. 35 Patients with COVID-19 pneumonia who were on ventilation were given iNO as part of routine care when they were failing to respond to best standard treatments. Name:Dr Tom WongEmail:T.Wong2@rbht.nhs.uk, Study contact information Phase III PoCC pivotal trial #1 BI 1015550 - PDE4 inhibitor in AF experienced PF-ILD. Professor Stephen Durham. A phase 1, open-label, single-dose, non-randomised study to evaluate pharmacokinetics and pharmacodynamics of edoxaban in pediatric patients, Study contact information Name:Dr Melissa SanchezEmail:M.Sanchez@rbht.nhs.uk, Principal investigator Office 707 S Garfield Ave Ste 101 Alhambra, CA 91801 Phone+1 626-282-1600 Fax+1 626-656-1261 Is this information wrong? Study Name: Anelise Catelan ZborowskiEmail: a.catelanzborowski@rbht.nhs.uk, Study Summary Dr. Benjamin Tam, MD is a board certified orthopedic surgeon in Alhambra, California. Acute muscle wasting in critical illness an observational cohort study. EARSATS-19: In-ear measurement of blood oxygen saturation in COVID-19 follow up, Study contact information